DeepMed Research

Vanderbilt University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1873-01-01

Employees: 10K

Market Cap: -

Website: http://www.vanderbilt.edu

Clinical Trials

Using Baby Books to Promote Maternal and Child Health

Not Applicable

Completed

Conditions: Condition 3 - Control Condition (No-book Group)
Condition 1 - Educational Condition (Educational Book Group)
Condition 2 - Non-educational Condition (Non-educational Book Group)

Interventions: Behavioral: Educational Content/Pediatric Anticipatory Guidance
Behavioral: Book provision

First Posted Date: 2014-07-30

Last Posted Date: 2017-04-14

Lead Sponsor: Vanderbilt University

Target Recruit Count: 198

Registration Number: NCT02203617

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States
🇺🇸
University of California, Irvine, Irvine, California, United States

Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome

Active, not recruiting

Conditions: Postural Orthostatic Tachycardia Syndrome

Interventions: Other: History
Other: Physical
Other: blood draw
Behavioral: Questionnaires

First Posted Date: 2014-07-22

Last Posted Date: 2024-10-02

Lead Sponsor: Vanderbilt University

Target Recruit Count: 212

Registration Number: NCT02196376

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Comparative Effects of Aspirin and NHP-544C

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Bradykinin
Drug: Aspirin 81 mg
Drug: NHP544-C 81 mg
Drug: Aspirin 162 mg
Drug: NHP544C 162 mg
Drug: Placebo

First Posted Date: 2014-07-14

Last Posted Date: 2016-07-12

Lead Sponsor: Vanderbilt University

Target Recruit Count: 61

Registration Number: NCT02189122

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial

Phase 1

Completed

Conditions: Asthma
Acute Chest Syndrome
Sickle Cell Disease

Interventions: Drug: Budesonide inhalation suspension

First Posted Date: 2014-07-11

Last Posted Date: 2017-02-17

Lead Sponsor: Vanderbilt University

Target Recruit Count: 36

Registration Number: NCT02187445

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

A Randomized Controlled Trial of a Conservative Fluid Balance Strategy for Patients With Sepsis and Cardiopulmonary Dysfunction (BALANCE Study)

Not Applicable

Completed

Conditions: Sepsis

Interventions: Other: Conservative Fluid Management Strategy

First Posted Date: 2014-06-09

Last Posted Date: 2019-11-01

Lead Sponsor: Vanderbilt University

Target Recruit Count: 30

Registration Number: NCT02159079

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Phenotypic Specific Communication Intervention for Children With Down Syndrome

Not Applicable

Completed

Conditions: Language Impairment
Down Syndrome

Interventions: Behavioral: Jasper-EMT with words and AAC

First Posted Date: 2014-06-06

Last Posted Date: 2018-07-12

Lead Sponsor: Vanderbilt University

Target Recruit Count: 78

Registration Number: NCT02158390

Locations: 🇺🇸
University of California, Los Angeles Center for Autism Research and Treatment, Los Angeles, California, United States
🇺🇸
Vanderbilt University Kennedy Center, Nashville, Tennessee, United States

Water and Sudafed in Autonomic Failure

Early Phase 1

Terminated

Conditions: Shy-Drager Syndrome
Multiple System Atrophy

Interventions: Drug: Pseudoephedrine + 50 ml water
Other: Placebo + 50 ml water (optional)
Drug: Pseudoephedrine + 480 ml water
Other: Placebo + 480 ml water (optional)

First Posted Date: 2014-05-29

Last Posted Date: 2021-05-05

Lead Sponsor: Vanderbilt University

Target Recruit Count: 35

Registration Number: NCT02149901

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Intravitreal Celecoxib for Chronic Uveitis

Phase 1

Terminated

Conditions: Inflammation

Interventions: Drug: Intravitreal Celecoxib

First Posted Date: 2014-05-06

Last Posted Date: 2017-02-23

Lead Sponsor: Vanderbilt University

Target Recruit Count: 4

Registration Number: NCT02131012

Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

Not Applicable

Completed

Conditions: Hypertension
Type 2 Diabetes Mellitus

Interventions: Drug: Placebo
Drug: Sitagliptin
Drug: Aprepitant
Other: Mixed Meal Test (MMT)

First Posted Date: 2014-05-05

Last Posted Date: 2022-03-02

Lead Sponsor: Vanderbilt University

Target Recruit Count: 106

Registration Number: NCT02130687

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

Neuroplasticity-Based Cognitive Remediation for Pediatric Brain Tumor Survivors

Not Applicable

Completed

Conditions: Brain Tumor

Interventions: Behavioral: Cognitive training

First Posted Date: 2014-05-02

Last Posted Date: 2018-09-06

Lead Sponsor: Vanderbilt University

Target Recruit Count: 40

Registration Number: NCT02129712

Locations: 🇺🇸
Vanderbilt University, Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy